SELVITA S.A. Financials Selvita S.A. Deutsche Boerse AG
Equities
787
PLSLVCR00029
Biotechnology & Medical Research
|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 15.08 EUR | -3.21% |
|
-8.38% | +11.21% |
| 05-22 | Selvita S.A. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
| 05-07 | Selvita S.A. acquired PozLab sp. z o.o from YouNick Mint Sp. z o.o. | CI |
Valuation
| Fiscal Period: December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|
| Capitalization 1 | 375.3 | 904.9 | 1,505 | 1,522 | 1,074 | 1,211 | - | - |
| Enterprise Value (EV) 1 | 375.3 | 843 | 1,588 | 1,659 | 1,074 | 1,402 | 1,433 | 1,480 |
| P/E ratio | 28 x | 47 x | 101 x | 48.8 x | 15.4 x | 17.4 x | 28.1 x | 17.7 x |
| Yield | - | - | - | - | - | - | - | - |
| Capitalization / Revenue | 3.57 x | 6.35 x | 4.77 x | 3.66 x | 3.05 x | 3.09 x | 2.53 x | 2.11 x |
| EV / Revenue | 3.57 x | 5.92 x | 5.03 x | 3.99 x | 3.05 x | 3.58 x | 2.99 x | 2.58 x |
| EV / EBITDA | - | 25.5 x | 18.7 x | 14.8 x | 14.6 x | 15.8 x | 12.3 x | 11.6 x |
| EV / FCF | - | 58.7 x | 26.5 x | 177 x | 78 x | -73.8 x | -23.9 x | -56.1 x |
| FCF Yield | - | 1.7% | 3.77% | 0.57% | 1.28% | -1.35% | -4.18% | -1.78% |
| Price to Book | - | 5.75 x | 7.65 x | 5.8 x | - | 4.09 x | 3.58 x | 2.86 x |
| Nbr of stocks (in thousands) | 15,971 | 18,355 | 18,355 | 18,355 | 18,355 | 18,355 | - | - |
| Reference price 2 | 23.50 | 49.30 | 82.00 | 82.90 | 58.50 | 66.00 | 66.00 | 66.00 |
| Announcement Date | 20-03-26 | 21-03-30 | 22-03-31 | 23-03-30 | 24-03-27 | - | - | - |
1PLN in Million2PLN
Estimates
Income Statement Evolution (Annual data)
| Fiscal Period: December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|
| Net sales 1 | 105.2 | 142.5 | 315.7 | 415.8 | 351.9 | 391.6 | 479.3 | 573.7 |
| EBITDA 1 | - | 33.1 | 85.04 | 112.4 | 73.71 | 88.92 | 116.5 | 127.5 |
| EBIT 1 | - | 19.57 | 57.55 | 44.78 | 16.75 | 31 | 62.02 | 85.4 |
| Operating Margin | - | 13.74% | 18.23% | 10.77% | 4.76% | 7.92% | 12.94% | 14.89% |
| Earnings before Tax (EBT) 1 | - | 18.85 | 21.07 | 40.21 | 67.2 | 22.8 | 52.9 | 84.5 |
| Net income 1 | - | 18 | 14.9 | 30.31 | 69.88 | 18 | 43.9 | 64.6 |
| Net margin | - | 12.63% | 4.72% | 7.29% | 19.86% | 4.6% | 9.16% | 11.26% |
| EPS 2 | 0.8400 | 1.050 | 0.8120 | 1.700 | 3.800 | 3.800 | 2.350 | 3.730 |
| Free Cash Flow 1 | - | 14.35 | 59.95 | 9.376 | 13.77 | -19 | -59.9 | -26.4 |
| FCF margin | - | 10.07% | 18.99% | 2.25% | 3.91% | -4.85% | -12.5% | -4.6% |
| FCF Conversion (EBITDA) | - | 43.37% | 70.49% | 8.34% | 18.68% | - | - | - |
| FCF Conversion (Net income) | - | 79.75% | 402.34% | 30.93% | 19.7% | - | - | - |
| Dividend per Share | - | - | - | - | - | - | - | - |
| Announcement Date | 20-03-26 | 21-03-30 | 22-03-31 | 23-03-30 | 24-03-27 | - | - | - |
1PLN in Million2PLN
Estimates
Income Statement Evolution (Quarterly data)
| Fiscal Period: December | 2021 Q4 | 2022 Q1 | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 |
|---|---|---|---|---|---|---|---|---|---|---|
| Net sales 1 | 93.01 | 95.02 | 103.4 | 109.1 | 108.3 | 91.81 | 89.14 | 84.18 | 86.84 | 77.36 |
| EBITDA 1 | 27.1 | 16.71 | 28.56 | 29.74 | 26.46 | 19.1 | 21.22 | 16.96 | 16.43 | 11.65 |
| EBIT 1 | - | 7.858 | 7.65 | 14.73 | 14.53 | 4.275 | 5.386 | 3.317 | 3.768 | -2.082 |
| Operating Margin | - | 8.27% | 7.4% | 13.51% | 13.42% | 4.66% | 6.04% | 3.94% | 4.34% | -2.69% |
| Earnings before Tax (EBT) | - | - | - | - | - | - | - | - | - | - |
| Net income 1 | 8.147 | 4.894 | - | 8.993 | 12.7 | 2.447 | 7.875 | -4.272 | 63.83 | -2.136 |
| Net margin | 8.76% | 5.15% | - | 8.25% | 11.73% | 2.67% | 8.83% | -5.07% | 73.5% | -2.76% |
| EPS | - | - | - | - | - | - | - | - | - | - |
| Dividend per Share | - | - | - | - | - | - | - | - | - | - |
| Announcement Date | 22-03-31 | 22-05-31 | 22-09-16 | 22-11-09 | 23-03-30 | 23-05-30 | 23-09-27 | 23-11-15 | 24-03-27 | 24-05-22 |
1PLN in Million
Estimates
Balance Sheet Analysis
| Fiscal Period: December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|
| Net Debt 1 | - | - | 82.8 | 138 | - | 191 | 221 | 268 |
| Net Cash position 1 | - | 61.9 | - | - | - | - | - | - |
| Leverage (Debt/EBITDA) | - | - | 0.9738 x | 1.225 x | - | 2.148 x | 1.899 x | 2.105 x |
| Free Cash Flow 1 | - | 14.4 | 59.9 | 9.38 | 13.8 | -19 | -59.9 | -26.4 |
| ROE (net income / shareholders' equity) | - | 19.1% | 24.5% | 13.2% | - | 5% | 12.2% | 13.4% |
| ROA (Net income/ Total Assets) | - | 11.6% | 12.3% | - | - | - | - | - |
| Assets 1 | - | 154.8 | 121.2 | - | - | - | - | - |
| Book Value Per Share 2 | - | 8.570 | 10.70 | 14.30 | - | 16.10 | 18.40 | 23.10 |
| Cash Flow per Share | - | - | - | - | - | - | - | - |
| Capex 1 | - | 15 | 27.5 | 79.8 | 65.2 | 49.2 | 56.6 | 97.4 |
| Capex / Sales | - | 10.53% | 8.72% | 19.19% | 18.53% | 12.56% | 11.8% | 16.98% |
| Announcement Date | 20-03-26 | 21-03-30 | 22-03-31 | 23-03-30 | 24-03-27 | - | - | - |
1PLN in Million2PLN
Estimates
EPS & Dividend
Year-on-year evolution of the PER
Change in Enterprise Value/EBITDA
Trading Rating
Investor Rating
ESG Refinitiv
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
5
Last Close Price
66
PLN
Average target price
68.98
PLN
Spread / Average Target
+4.52%
EPS Revisions
Quarterly revenue - Rate of surprise
| 1st Jan change | Capi. | |
|---|---|---|
| +11.60% | 106B | |
| -4.68% | 24.28B | |
| -0.82% | 21.96B | |
| -10.12% | 18.16B | |
| -42.12% | 16.37B | |
| -17.47% | 15.56B | |
| +2.77% | 13.63B | |
| +34.58% | 12.27B | |
| +77.64% | 8.87B |
- Stock Market
- Equities
- SLV Stock
- 787 Stock
- Financials Selvita S.A.
